Optional Non-CME Satellite Presentations

Obesity & Semaglutide 2.4mg Updates

Dagmawit Betru, PharmD
Medical Liaison – Obesity
Novo Nordisk, Inc.

Rachel Rocha, PharmD, BC-ADM, CDCES
Medical Liaison – Obesity
Novo Nordisk, Inc.

Nash Haleem, DVM, FMCHC
Executive Medical Liaison – Obesity
Novo Nordisk, Inc.

Virtual Teams Meeting Link
Meeting ID: 344 046 871 051
Passcode: Ermk9P

View the Flyer Here

Please scan QR Code to RSVP:

This program is developed and offered by Novo Nordisk, Inc.

Recognizing Progressive Pulmonary Fibrosis (PPF)

Fortune Alabi, MD, MBA, FCCP, ABSM
Director at Florida Lung, Asthma & Sleep Specialists, PA
Medical Director of Intensive Care Unit
Director of Respiratory Care
Celebration, FL

Virtual Zoom Meeting Pre-Registration Link

This program is developed and offered by Boehringer Ingelheim Pharmaceuticals, Inc.

Understanding the Impact of CVOTs on Diabetes Guidelines

Alexandria A. Opata, MD
Scientific Director, Diabetes - South
Novo Nordisk, Inc.

Daniela Fernandez, PharmD
Medical Liaison, Diabetes – South Florida
Novo Nordisk, Inc.

Please RSVP to Daniela Fernandez at [email protected]

Virtual Teams Meeting Link
Meeting ID: 375 692 245 452
Passcode: dQxirf

This program is developed and offered by Novo Nordisk, Inc.